| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From Johnson and Johnson Pharmaceutical Research and Development,* Spring House, Pennsylvania; and the Department of Physiology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Inflammation underlines all major bladder pathologies and represents a defense reaction to injury involving a mandatory participation of mast cells and sensory nerves. Mast cells are particularly frequent in close proximity to epithelial surfaces where they are strategically located in the bladder and release their mediators in response to inflammation. Tryptase is specifically produced by mast cells and modulates inflammation by activating protease-activated receptors (PARs). We recently found that PAR-4 mRNA is up-regulated in experimental bladder inflammation regardless of the initiating stimulus. Because it has been reported that PAR-1, PAR-2, and PAR-3 may also be involved in the processes of inflammation, we used immunohistochemistry to characterize the expression of all known PARs in normal, acute, and chronic inflamed mouse bladder. We found that all four PARs are present in the control mouse bladder, and follow a unique distribution. All four PARs are co-expressed in the urothelium, whereas PAR-1 and PAR-2 are predominant in the detrusor muscle, and PAR-4 is expressed in peripheral nerves and plexus cell bodies. The strong expression of PARs in the detrusor muscle indicates the need for studies on the role of these receptors in motility whereas the presence of PAR-4 in nerves may indicate its participation in neurogenic inflammation. In addition, PARs are differentially modulated during inflammation. PAR-1 and PAR-2 are down-regulated in acute inflammation whereas PAR-3 and PAR-4 are up-regulated. Bladder fibroblasts were found to present a clear demarcation in PAR expression secondary to acute and chronic inflammation. Our findings provide evidence of participation of PARs in the urinary system, provide a working model for mast cell tryptase signaling in the mouse bladder, and evoke testable hypotheses regarding the roles of PARs in bladder inflammation. It is timely to understand the role of tryptase signaling and PARs in the context of bladder biology.
This article has been cited by other articles:
 |
|
 |
|
  F. A. Russell, V. E. Veldhoen, D. Tchitchkan, and J. J. McDougall Proteinase-Activated Receptor-4 (PAR4) Activation Leads to Sensitization of Rat Joint Primary Afferents Via a Bradykinin B2 Receptor-Dependent Mechanism J Neurophysiol, January 1, 2010; 103(1): 155 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Khandelwal, S. N. Abraham, and G. Apodaca Cell biology and physiology of the uroepithelium Am J Physiol Renal Physiol, December 1, 2009; 297(6): F1477 - F1501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-Y. Wang, P. Wang, and D. E. Bjorling Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2009; 297(4): R1127 - R1135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Saban, M. R. Saban, J. Maier, B. Fowler, M. Tengowski, C. A. Davis, X.-R. Wu, D. J. Culkin, P. Hauser, J. Backer, et al. Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1613 - F1623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Saban, J. M. Backer, M. V. Backer, J. Maier, B. Fowler, C. A. Davis, C. Simpson, X.-R. Wu, L. Birder, M. R. Freeman, et al. VEGF receptors and neuropilins are expressed in the urothelial and neuronal cells in normal mouse urinary bladder and are upregulated in inflammation Am J Physiol Renal Physiol, July 1, 2008; 295(1): F60 - F72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Rastogi, A. Rickard, N. Dorokhov, D. J. Klumpp, and J. McHowat Loss of prostaglandin E2 release from immortalized urothelial cells obtained from interstitial cystitis patient bladders Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1129 - F1135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rullier, J. Gillibert-Duplantier, P. Costet, G. Cubel, V. Haurie, C. Petibois, D. Taras, N. Dugot-Senant, G. Deleris, P. Bioulac-Sage, et al. Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G226 - G235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Slofstra, M. F. Bijlsma, A. P. Groot, P. H. Reitsma, T. Lindhout, H. ten Cate, and C. A. Spek Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation Blood, November 1, 2007; 110(9): 3176 - 3182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ramachandran, L. R. Sadofsky, Y. Xiao, A. Botham, M. Cowen, A. H. Morice, and S. J Compton Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4 Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L788 - L798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Birder More than just a barrier: urothelium as a drug target for urinary bladder pain Am J Physiol Renal Physiol, September 1, 2005; 289(3): F489 - F495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. D'Andrea, J. M. Mei, R. W. Tuman, R. A. Galemmo, and D. L. Johnson Validation of in vivo pharmacodynamic activity of a novel PDGF receptor tyrosine kinase inhibitor using immunohistochemistry and quantitative image analysis Mol. Cancer Ther., August 1, 2005; 4(8): 1198 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. D'Andrea, Y. Qiu, D. Haynes-Johnson, S. Bhattacharjee, P. Kraft, and S. Lundeen Expression of PDE11A in Normal and Malignant Human Tissues J. Histochem. Cytochem., July 1, 2005; 53(7): 895 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Kimball, J. M. Palmer, M. R. D'Andrea, P. J. Hornby, and P. R. Wade Acute colitis induction by oil of mustard results in later development of an IBS-like accelerated upper GI transit in mice Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1266 - G1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Adam, S. H. Eaton, C. Estrada, A. Nimgaonkar, S.-C. Shih, L. E. H. Smith, I. S. Kohane, D. Bagli, and M. R. Freeman Mechanical stretch is a highly selective regulator of gene expression in human bladder smooth muscle cells Physiol Genomics, December 15, 2004; 20(1): 36 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Rohatgi, F. Sedehizade, K. G. Reymann, and G. Reiser Protease-Activated Receptors in Neuronal Development, Neurodegeneration, and Neuroprotection: Thrombin as Signaling Molecule in the Brain Neuroscientist, December 1, 2004; 10(6): 501 - 512. [Abstract] [PDF]
|
|
|
|
 |
|
 F Mule, R Pizzuti, A Capparelli, and N Vergnolle Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon Gut, February 1, 2004; 53(2): 229 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Dozmorov, M. R. Saban, N. Knowlton, M. Centola, and R. Saban Connective molecular pathways of experimental bladder inflammation Physiol Genomics, November 11, 2003; 15(3): 209 - 222. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
